| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |